Abstract: Science Set Journal of Ophthalmology and Eye Care

Abstract:
Purpose: The aim of present study was to look for possible visual evoked potential (VEP) changes in the patient’s experiencing headache as a consequence of Dinogest treatment.

Patients and Methods: A total of 22 eyes from 11 females aged between 25 and 42 years who received Dinogest for the treatment of endometriosis and expriencing headache as a side effect of Dinogest were included as the case group. VEP measurements were taken from the case group and compared with results from 22 eyes of 11 healthy females with no history of Dinogest use, who served as the control group.

Result: There were no significant differences between the case and control groups in terms of the latency and ampli tude of VEP P100 Peak.

Conclusion: No VEP changes was observed in the endometriosis Patients using Dinogest and experiencing headache as a consequence of treatment.